Search

Author/Creator Miles, D

1. 321PResponse evaluation of cancer therapeutics in metastatic breast cancer to the bone: A single arm phase II study of whole-body magnetic resonance imaging. (23rd October 2018)

Authors:
Kosmin, M; Padhani, A R; Gogbashian, A; Woolf, D; Ah-See, M-L; Ostler, P; Sutherland, S; Miles, D; Noble, J; Marshall, A; Dunn, J; Makris, A
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A service evaluation of joint working across sectors to promote self-administration of subcutaneous systemic anti-cancer therapy in breast cancer patients. (30th November 2022)

Authors:
Dodhia, V; Ng, H W; Alves, C; Wojtas, M; Miles, D; Guppy, A; James, S; Harrold, K; Adisa, A; Tome, T; Lyner, Z; Bennett, J; Majid, R
Journal:
International journal of pharmacy practice
Issue:
Volume 30(2022)Supplement 2
Page Start:
ii17
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE). (23rd February 2019)

Authors:
Bachelot, T; Ciruelos, E; Schneeweiss, A; Puglisi, F; Peretz-Yablonski, T; Bondarenko, I; Paluch-Shimon, S; Wardley, A; Merot, J -L; du Toit, Y; Easton, V; Lindegger, N; Miles, D
Journal:
Annals of oncology
Issue:
Volume 30:Number 5(2019)
Page Start:
766
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗